Welcome to Oncologynurseadvisor.com - Breast, Lung, Brain, Bone Cancer | News, Research & Treatment Articles

oncologynurseadvisor.com

Description: Oncologynurseadvisor. More news » Challenges Faced By Oncology Nurses https://polldaddy.com/poll/10020480/ Editorial Board Eucharia Borden,...

Google PR 5

Trustworthiness Good
Avg. Daily Visitors 505

Child Safety Unknown
Avg. Daily Pageviews 505

Privacy Good

Breast, Lung, Brain, Bone Cancer | News, Research & Treatment Articles - ONA

Oncologynurseadvisor.com: get to the top rated Oncologynurseadvisor pages and content popular with USA-based Oncologynurseadvisor.com users or check the following digest to find out more. Oncologynurseadvisor.com is a malware-free website without age restrictions, so you can safely browse it. It seems that Oncologynurseadvisor team are just starting to conquer the social media and they have already achieved a promising result — 101 user activities so far (Google+ dominates with around 87% of all user reactions). Oncologynurseadvisor.com is hosted with CloudFlare, Inc. in United States. Oncologynurseadvisor traffic is estimated at around 15.1K visits per month.

Visit oncologynurseadvisor.com

Domain info

Location:	United States
Registrant:	Haymarket Media Group Ltd.
Hosted by:	CloudFlare, Inc.
Registrar:	CSC Corporate Domains, Inc.
Subnetworks:	104.18.0.13, 104.18.1.13

Alexa's Traffic Estimates & Trends

Traffic Rank:	133 707
Month Average Daily Reach:	0.000069	-4.5%
Month Average Daily Pageviews:	0.000002	-1.0%

More details from Alexa

Social Media Activities

Facebook likes: 1
Twitter mentions: 3
Google pluses: 88
LinkedIn mentions: 8
Pinterest pins: -
StumbleUpon views: 1

Web Safety

This website is malware-free.
Status ok

See Google Transparency Report

Sites associated with the same registrant

Whois

Expand

Oncologynurseadvisor.com popular pages to visit

Oral Baricitinib Evaluated in RA Unresponsive to Conventional DMARDs - ONA Eli Lilly and Incyte announced positive data from the pivotal study, RA-BEYOND, evaluating baricitinib vs. placebo for the treatment of rheumatoid arthritis (RA). Study findings were presented at the ...

A Protein Could Predict the Response to Immunotherapy in Metastatic Melanoma - Oncology Nurse Advisor The Bim protein might predict which patients could be successfully treated with immunotherapy for metastatic melanoma.

Breast, Lung, Brain, Bone Cancer | News, Research & Treatment Articles - ONA More news » Challenges Faced By Oncology Nurses https://polldaddy.com/poll/10020480/ Editorial Board Eucharia Borden, MSW, LCSW, OSW-C Ann J.